Owensboro, KY, United States of America

Krystal Hamorsky

This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignees: University Of Louisville Research Foundation, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Krystal Hamorsky. Retrieved from https://idiyas.com/inventor/krystal-hamorsky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Krystal Hamorsky in Biotechnology**

Introduction

Krystal Hamorsky, an accomplished inventor based in Owensboro, KY, has made significant contributions to the field of biotechnology through her innovative research and developments. With a total of two patents to her name, her work primarily focuses on cholera toxin B subunit variants and their applications in medicine.

Latest Patents

Hamorsky's latest patents detail groundbreaking advancements in the formulation and use of cholera toxin B subunit variants. One patent describes the development of a spray-dried formulation that includes both powder and pharmaceutical compositions incorporating the cholera toxin B subunit variant alongside saccharide excipients. These compositions have promising implications for treating diseases and enhancing wound healing.

Another important patent outlines methods for producing polypeptides with immunoactivating activity. This invention consists of isolated polypeptides that feature a cholera toxin B subunit variant, strategically modified to enhance expression within plant cells. Additionally, the patent provides comprehensive methodologies for producing these variant polypeptides, including transforming plant cells with specific nucleic acids and subsequent purification of the expressed proteins.

Career Highlights

Krystal Hamorsky is affiliated with the University of Louisville Research Foundation, Inc., where she actively engages in research that advances the understanding and application of immunotherapeutic agents. Her innovative discoveries have contributed to the foundation's mission of fostering health-related research and technology.

Collaborations

In her endeavors, Hamorsky collaborates with Nobuyuki Matoba, a fellow researcher whose insights complement her work. This partnership enhances the innovative potential of their shared research goals, particularly in the exploration of immunological applications of cholera toxin B subunit variants.

Conclusion

Krystal Hamorsky's inventive spirit and commitment to advancing biotechnology underscore her contributions in the field. Through her patents, she continues to pave the way for future research and developments that have the potential to significantly impact medical treatments and therapeutic strategies. Her collaboration with others, like Nobuyuki Matoba, further emphasizes the importance of teamwork in the pursuit of scientific innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…